Danaher Corporation (NYSE:DHR) and AstraZeneca PLC (NASDAQ:AZN) have announced a major partnership to accelerate the ...

DHR and AstraZeneca team up to develop AI-powered diagnostics, aiming to boost precision medicine by improving patient ...

Danaher Corp. closed 32.84% short of its 52-week high of $281.70, which the company reached on August 1st.

Shares of Danaher Corp. slipped 4.47% to $187.82 Wednesday, on what proved to be an all-around mixed trading session for ...

Shares of Danaher Corp. slipped 5.54% to $186.81 Wednesday, on what proved to be an all-around poor trading session for the ...

The companies will develop and commercialize diagnostic tools to help clinicians determine which patients would benefit from precision medicine treatments.

Danaher Corporation, a key player in Life Sciences, Biotechnology, and Diagnostics, has shown mixed financial performance with recent declines in revenue and net earnings. Despite recent struggles ...

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments ...

Aug 28 (Reuters) - Danaher Corp (DHR.N), opens new tab on Monday agreed to buy protein consumables manufacturer Abcam Plc in a $5.7 billion all-cash deal including debt, as the medical tools ...

KENTWOOD, MI — Delaware conglomerate Danaher Corp. has completed the takeover of color products-maker X-Rite this month while a class action shareholder lawsuit quietly proceeds in the background.

Sept 14 (Reuters) - Danaher Corp (DHR.N), opens new tab said on Wednesday it would separate its environmental & applied solutions (EAS) segment to pivot growth towards the medical technology firm ...

About a year ago, Danaher Corporation's (NYSE: DHR) valuation looked cheap relative to its peers. Of course, when I write peers, I mean its medical, life sciences, and diagnostics peers because ...